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Specific role for phosphate
We learned many years ago that phosphate can induce hyperparathyroidism by decreasing the levels of 1,25 or by inducing hypocalcemia. But we and others have shown in the past five years that phosphate, per se, independent of calcitriol, independent of calcium, has a direct effect on the secretion of parathyroid hormone.
My role tonight is to concentrate on this part, in the so-called phosphate, and since tonight we are going to have another symposium with another pharmaceutical company, tomorrow we're going to do the vitamin D part. Then if you come to both of them, you get the whole picture. But tonight I'm supposed to talk about this part of this scheme.
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Importance of parathyroid gland hyperplasia in uremia
It's not only important to control hyperparathyroidism, but to control the growth of the parathyroid cell. When a patient or an animal develops chief cell hyperplasia, it's almost impossible to bring the cells back to normal. We may reduce the volume, but not the hyperplasia. And there is no apoptosis. That is, when a patient has very large glands, although we may have seen some changes in the size of parathyroid gland, the change is very small, and the change in DNA is practically zero. That is critical, the prevention. Since we know that low calcium and low vitamin D, or high phosphorus will induce hyperplasia, and we are studying the effect of the receptors, and some growth factors are important.
Role for phosphate via TGF in causing parathyroid gland hyperplasia
We know now, for the first time, that TGF-alpha is induced by hyperphosphatemia and increases the cells in the parathyroid gland. Those of you who would like to know a little more about TGF-alpha it will be present in great detail by one of our collaborators, Dr. Adriana Dusso, tomorrow in the 4:00 to 6:00 pm meeting in PTH and PTHrP (Dusso AS et al, A role for enhanced expression of transforming growth factor-alpha (TGF-alpha) in the mitogenic effect of high dietary phosphorus on parathyroid cell growth in uremia. J Am Soc Nephrol (abstract) 10:617A, 1999). High phosphate diet in uremic dogs induces, and low phosphate diet prevents, hyperparathyroidism This slide is about 35 years old, and was shown this morning by my good friend, Dr. S. Klahr, and was the first demonstration that if you induce renal failure in dogs, and you feed them a normal phosphate intake, they develop hyperparathyroidism.
On the other hand, if you restrict phosphorus in the diet, in blue, they did not develop hyperparathyroidism. Remember, this was the late '60's, and we didn't know anything about calcitriol, we didn't know anything about receptors. But that was the first indication that phosphorus was doing something to the parathyroid glands. I'm going to go past 75 slides, otherwise it will take me the whole night, next slide please, and I'm going to show the results from the past two or three years. 
Phosphorus enrichment of culture media induces increased PTH synthesis by cultured parathyroid glands
What we have shown two or three years ago, that if you incubate parathyroid glands from normal rats and you increase the amount of phosphorus in the culture medium from 0.2 to 2.8 mM and for those of you who are accustomed to mg/dl, you have to multiply by 3.1, as you increase the amount of phosphorus in the culture medium, there is a significant increase in the release of PTH. The levels of calcium and calcitriol in the culture medium were identical.
Other investigators, Moreno Rodriguez and his group, Dr. Silver in Jerusalem and his group, and several others have shown the same results. Finally, after 35 years, there is agreement between investigators, that phosphorus, per se, produces secondary hyperparathyroidism. 
Effects of high vs low phosphorus diet in uremic rats on parathyroid gland size
What about chief cell hyperplasia? Can phosphorus also increase the size of the parathyroid glands? What we did is the following experiment. We took normal rats and uremic rats, and we fed them a low phosphorus diet, 0.2 mM, or a high phosphorus diet, 0.8 mM. And the results are depicted in the next slide. Parathyroid gland weight is increased only in uremic rats on the high phosphorus diet In blue, I have depicted the normal rats, and in red, you may not be able to see it very well, are uremic rats. If you can please concentrate here, these are the uremic rats who received the low phosphorus diet. And here we have PTH. As you can see, they did not develop secondary hyperparathyroidism. The level of PTH is the same like normal animals.
On the other hand, the uremic animals, on a high phosphorus diet, PTH increased from 30 to 120. These animals developed secondary hyperparathyroidism.
If you think for a minute, I have not told you anything new, that I didn't tell you 35 years ago. Because we showed that, in dogs, when we restricted the diet. But at that time, we didn't measure the size of the parathyroid glands, we didn't measure protein and DNA, and we have done it now, and those animals on a low phosphorus diet, the size of the gland, DNA, and protein is the same like normal. On the other hand, on a high phosphorus diet, they develop chief cell hyperplasia. Thus, not only did we induce hyperplasia, but also we get hyperparathyroidism, independent of calcium, and independent of calcitriol. 
PCNA (Proliferative Cell Nuclear Antigen) is increased in uremic rats on a normal or high phosphorus diet, but prevented by a low phosphorus diet
By a totally different methodology, Dr. Naveh-Many, working with Dr. Silver in Jerusalem, they measured PCNA. PCNA means proliferative cell nuclear antigen. It's a marker of cell mitosis. The more PCNA you have means that the cells are dividing more and more and more. If you look at normal parathyroid tissue, it's very quiescent, you don't see any division, and the number of mitosis are extremely low. If you make the animals uremic, the number of mitosis increases. If you make them uremic and feed a high phosphorus diet, the number of mitosis is even greater.
The point I want to make is not that one, but this one here. That uremic animals, who were fed a low phosphorus diet, the number of mitosis is the same as normal animals. Then, by two different types of methodologies, them and us, we clearly show that if we can restrict phosphorus early, we can prevent the development of chief cell hyperplasia. High-to-low phosphorus diet in uremic rats: effect on serum phosphate levels The question that we ask ourselves is, if we have hyperplasia, because we've fed the high phosphorus diet, what happens if now we change the diet, and we feed a low phosphorus diet. What changes will happen to the parathyroid glands?
Here you can see the animals on the low phosphorus diet, always in blue, they will have a low phosphorus; and a high phosphorus diet, of course, they develop hyperphosphatemia. And when we switch from red to yellow, it means that we go from a high to a low phosphorus diet. When we went here to a low phosphorus diet, of course, as suspected, the serum phosphorus will decrease. These are expected results according to the intake of phosphorus. High-to-low phosphorus diet in uremic rats: effect on serum PTH levels What happened with PTH? In the animals on a low phosphorus diet, in blue, and we follow them now up to 90 days, they never developed secondary hyperparathyroidism. In red, as you cannot see it well, after two weeks on a high phosphorus diet, they have significant hyperparathyroidism. However, when we go from a high phosphorus to a low phosphorus diet, from red to yellow, PTH returns back to normal. Then we can reverse secondary hyperparathyroidism, at least in the rat.
Direct vs. indirect mechanisms whereby hyperphosphatemia induces secondary hyperparathyroidism
Now I want to summarize here by saying hyperphosphatemia induces hyperparathyroidism by two independent mechanisms. One indirect, known by everybody for the past 20, 25 years, by decreasing the levels of calcitriol, by decreasing the levels of calcium, and by inducing skeletal resistence. And directly, by producing chief cell hyperplasia, by increasing the synthesis of PTH, and therefore by increasing the secretion of PTH. Outcomes data: increased mortality associated with elevated Ca x P product But now we are also paying attention in another problem, mortality and morbidity. Dr. Block has shown that with a calcium phosphate product greater than 70, mortality increases. And as you well know, the high mortality in dialysis patients is due to cardiovascular effect, these patients have accelerated atherosclerosis. And if they have a high calcium phosphate product, they can calcify the atherosclerotic plaques. Then we try to control this serum phosphorus and calcium phosphate product as you will see in a minute.
I'd like to emphasize one problem, which is a serious one, of calciphylaxis. Calciphylaxis is a very complicated, serious complications with high mortality of 60 to 90 percent. Not always is it due to high calcium phosphate PTH product. Not always. But in a large number of patients it is. And I want to emphasize that we want to avoid, as much as we can, this problem that can be induced by high calcium phosphate product.
00:00
Calciphylaxis This mortality will be discussed in great detail by Dr. Chertow, so I'm not going to talk about this patient, but this is the type of problem that was I was referring to you, the calcification of the vessels. I apologize for this slide for your dinner, I hope you can take your dinner too. Sloughing of the skin.
In a recent paper published by Dr. Amann and Dr. Eberhard Ritz, they found that after a few months that a patient is in dialysis, gets severe calcification of the aortic valve. Then it is critical that we maintain a lower calcium phosphate product.
Concluding remarks: What is the desirable Ca x P product? And I'd like to finish my presentation with the last slide to emphasize that if you multiply the upper limit of calcium by the upper limit of phosphorus, it's not 70, it's 50. And we have accepted for a long time that a good calcium phosphate product was 70 to 75. I think that we have to change our approach.
In the past we used aluminum and we were wrong. We induced osteomalacia. In the past we used calcium carbonate and we thought that we were doing a good job, but we got a very high calcium phosphate product.
Today we can drop the serum phosphorus without producing hypercalcemia. And that will help us because if we keep the calcium phosphate product at a lower concentration, we will be able to use new vitamin D analogues, that tproduce less hypercalcemia and less hyperphosphatemia. That the combination of the two new drugs, the new phosphate binders, and the new vitamin D analogues, is going to help physicians to control secondary hyperparathyroidism. I'm going to finish here, and thank you very much.
